Selected article for: "acute describe and long covid"
Author: Nakamura, Zev M.; Nash, Rebekah P.; Laughon, Sarah L.; Rosenstein, Donald L.
Title: Neuropsychiatric Complications of COVID-19
  • Cord-id: tx8exr1q
  • Document date: 2021_3_16
    • ID: tx8exr1q
    Snippet: PURPOSE OF REVIEW: To describe the presentation, etiologies, and suggested management of post-acute COVID-19 neuropsychiatric symptoms. RECENT FINDINGS: Over 30% of patients hospitalized with COVID-19 may exhibit cognitive impairment, depression, and anxiety that persist for months after discharge. These symptoms are even more common in patients who required intensive care for severe effects of the virus. In addition to the pandemic-related psychological stress, multiple biological mechanisms ha
    Document: PURPOSE OF REVIEW: To describe the presentation, etiologies, and suggested management of post-acute COVID-19 neuropsychiatric symptoms. RECENT FINDINGS: Over 30% of patients hospitalized with COVID-19 may exhibit cognitive impairment, depression, and anxiety that persist for months after discharge. These symptoms are even more common in patients who required intensive care for severe effects of the virus. In addition to the pandemic-related psychological stress, multiple biological mechanisms have been proposed to understand the neuropsychiatric symptoms observed with COVID-19. Given limited research regarding effective interventions, we recommend pharmacologic and behavioral strategies with established evidence in other medically-ill populations. SUMMARY: Long-term, neuropsychiatric complications of COVID-19 are common and consequential. Because these are likely to co-occur with other medical problems, patients recovering from COVID-19 are best managed in clinics with highly coordinated care across disciplines and medical specialties. Future research is needed to inform appropriate interventions.

    Search related documents:
    Co phrase search for related documents
    • access facilitate and acute period: 1
    • access facilitate and acute phase: 1
    • access facilitate and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • access facilitate and acute sars respiratory syndrome: 1, 2, 3, 4
    • acetylcholinesterase inhibitor and acute respiratory syndrome: 1, 2
    • acute infection and liver inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute kidney injury and admission lab: 1, 2, 3
    • acute kidney injury and liver inflammation: 1, 2, 3, 4, 5
    • acute phase and liver inflammation: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and admission lab: 1
    • acute respiratory syndrome and liver inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute sars respiratory syndrome and liver inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18